Adverse events of hyperthermic intravesical chemotherapy for non-muscle invasive bladder cancer patients

Abstract

In the current study, we found that HIVEC was a well-tolerated treatment. HIVEC might be a feasible option for patients, who experienced BCG-failure or BCG-intolerance and could potentially postpone or avoid radical cystectomy.